POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF SALMON CALCITONIN AFTER ORAL ADMINISTRATION OF SMC021 IN HEALTHY SUBJECTS.

被引：0
|
作者：
Chigutsa, E. [1 ]
Ngaimisi-Kitabi, E. [1 ]
Sunkara, G. [2 ]
Choi, L. [2 ]
Bouillon, T. [1 ]
Jiang, X. [2 ]
机构：
[1] Novartis, Basel, Switzerland
[2] Novartis, E Hanover, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [1] EFFECT OF ESOMEPRAZOLE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF SMC021 IN HEALTHY VOLUNTEERS.
    Choi, L.
    Sivasubramanian, R.
    Bhad, P.
    Junker, U.
    Jones, J.
    Azria, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S125 - S125
  • [2] Efficacy and safety of a novel oral formulation of salmon calcitonin (SMC021) in postmenopausal women.
    Tankó, LB
    Bagger, YZ
    Reginster, JY
    Devogalar, JP
    Mindeholm, L
    Chick, R
    Benmammar, H
    Azria, M
    Christiansen, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S264 - S264
  • [3] Pharmacokinetics and pharmacodynamics of clomethiazole after oral and rectal administration in healthy subjects
    Rätz, AE
    Schlienger, RG
    Linder, L
    Langewitz, W
    Haefeli, WE
    [J]. CLINICAL THERAPEUTICS, 1999, 21 (05) : 829 - 840
  • [4] Synthesis and analysis of (3H) salmon calcitonin ((3H)SMC021)
    Ciszewska, Grazyna
    Allentoff, Alban
    Wu, Amy
    Ray, Tapan
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2007, 50 (5-6): : 455 - 456
  • [5] POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF PD 0348292, AN ORAL, DIRECT FACTOR XA INHIBITOR, IN HEALTHY SUBJECTS.
    Xuan, D.
    Boyd, R.
    DiCarlo, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S54 - S55
  • [6] Pharmacokinetics and pharmacodynamics of LC15-0444, a novel DPP IV inhibitor, after single oral administration in healthy subjects.
    Choi, Y. J.
    Lim, K. S.
    Kim, K. P.
    Cho, J. Y.
    Yu, K. S.
    Shin, S. G.
    Yim, H. J.
    Kwon, O. H.
    Lee, J. I.
    Kim, D. K.
    Jang, I. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S88 - S88
  • [7] Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis
    Bandeira, Leonardo
    Lewiecki, E. Michael
    Bilezikian, John P.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (06) : 681 - 689
  • [8] Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.
    Hassan-Alin, M
    Rohss, K
    Andersson, T
    Nyman, L
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A16 - A16
  • [9] Pharmacokinetics (PK) and pharmacodynamics (PD) of lanoteplase in healthy subjects.
    Vachharajani, N
    Shyu, W
    Stouffer, B
    Raymond, R
    Liao, W
    Tay, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 180 - 180
  • [10] EFFECTS OF DRONEDARONE ON PHARMACOKINETICS AND PHARMACODYNAMICS OF LOSARTAN IN HEALTHY SUBJECTS.
    Bonnet, Denis
    Galleyrand, Jacques
    Brunet, Aurelie
    Sultan, Eric
    Gaud, Christine
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1080 - 1080
12345